The findings could lead to better, faster treatment with antibiotics known to fight
these targeted bacterial strains.
Not exact matches
Since phages have evolved with their
bacterial targets for billions of years, they could solve the problem of antibiotic resistance for good; the downside is that each
bacterial strain requires its own tailored phage cocktail, so it could be many years before doctors have a suitably broad range of phages at their disposal.
Prof. Raymond Kaempfer, the Dr. Philip M. Marcus Professor of Molecular Biology and Cancer Research at the Institute for Medical Research Israel - Canada (IMRIC), in the Hebrew University's Faculty of Medicine, explains: «Rather than
targeting the
bacterial pathogens, which can then mutate to develop antibiotic resistance, host - oriented therapeutics have the advantage of remaining effective even against infections with antibiotic - resistant
strains.
Our research will contribute to a better mechanistic understanding of the microbes that live in our body, leading to the discovery of druggable small molecules, new
targets for antibacterial therapy and beneficial
bacterial strains that can be employed for intervention therapies.
Our research will contribute to a better mechanistic understanding of the microbes that live in our gut, leading to the discovery of druggable small molecules, new
targets for antibacterial therapy and beneficial
bacterial strains that can be employed for intervention therapies.